Leukemia Lymphoid

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2026-07-31
EMA Authorised: Iclusig (ponatinib) — Incyte Biosciences Distribution B.V.
The EMA authorizes Iclusig (ponatinib) for leukemia indications under accelerated assessment.